The Commission has developed resources for consumers, clinicians and health services on the use of transvaginal mesh products for the treatment of pelvic organ prolapse (POP) and stress urinary incontinence (SUI) and mesh removal.
Found 18 result(s)
The Commission has completed implementation of recommendations of the Senate Affairs References Committee’s report on the Number of women in Australia who have had transvaginal mesh implants and related matters and developed guidance and other resources for consumers, clinicians and health services.
The Commission has developed information for consumers on some key safety and quality issues, and health conditions.
The Commission's work encompasses numerous health conditions and treatments, across a number of program areas.